Alpha Paradigm Partners’s Quest Diagnostics DGX Stock Holding History

Alpha Paradigm Partners’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$1.26M	Buy	+8,071	New	+$1.16M	0.52%	48
2022 Q3	–	Sell	-5,220	Closed	-$694K	–	502
2022 Q2	$694K	Buy	5,220 +1,729	+50%	+$236K	0.29%	126
2022 Q1	$478K	Sell	3,491 -50	-1%	-$6.97K	0.19%	185
2021 Q4	$613K	Buy	3,541 +2,380	+205%	+$362K	0.25%	123
2021 Q3	$169K	Sell	1,161 -13,986	-92%	-$2.05M	0.07%	362
2021 Q2	$2M	Sell	15,147 -57	-0.4%	-$7.46K	0.75%	11
2021 Q1	$1.95M	Buy	15,204 +12,233	+412%	+$1.51M	0.76%	19
2020 Q4	$354K	Buy	+2,971	New	+$362K	0.12%	198

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Alpha Paradigm Partners's DGX Position: Q4 2022 in Review

Alpha Paradigm Partners opened a new position in Quest Diagnostics (DGX) in Q4 2022: 8,071 shares worth $1.26M. The stake represents 0.52% of the portfolio and ranks #48 among its holdings. This is a return to the name: Alpha Paradigm Partners previously reported a position in DGX as recently as Q2 2022.

Alpha Paradigm Partners first reported a position in DGX in Q4 2020 and has held it in 8 quarters since. The position peaked at $2M in Q2 2021. 879 funds tracked by Wall St. Rank hold DGX as of Q4 2022.

Alpha Paradigm Partners held 8,071 shares of Quest Diagnostics worth $1.26M as of Q4 2022.
Quest Diagnostics was a new Alpha Paradigm Partners position in Q4 2022.
Quest Diagnostics made up 0.52% of Alpha Paradigm Partners's portfolio in Q4 2022, its #48 holding.
Alpha Paradigm Partners first reported a position in Quest Diagnostics in Q4 2020 and has held it in 8 quarters since.
Alpha Paradigm Partners's Quest Diagnostics position peaked at $2M in Q2 2021.
879 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2022.

Based on Alpha Paradigm Partners's 13F filing for Q4 2022, filed 13 Feb 2023.